EPHA2 and neoplasm: Consistent with the other models, EphA2-ILs-DTXp at 59 mg/kg led to significant tumor regression with extended survival when compared with an equitoxic dose of free DTX at 10 mg/kg (ANOVA and post-hoc Tukey HSD; p < 0.05; Log-Rank Prob > ChiSq Survival: p < 0.05) (Figure 5B).